{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:47:19Z","timestamp":1792799239256,"version":"4.5.0"},"reference-count":36,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.3892\/or.2016.4615","type":"journal-article","created":{"date-parts":[[2016,2,8]],"date-time":"2016-02-08T12:28:53Z","timestamp":1454934533000},"page":"2373-2381","source":"Crossref","is-referenced-by-count":20,"title":["Decreased expression of the type III TGF-\u03b2 receptor enhances metastasis and invasion in hepatocellullar carcinoma progression"],"prefix":"10.3892","volume":"35","author":[{"given":"SEN","family":"ZHANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WU-YI","family":"SUN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JING-JING","family":"WU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUAN-JING","family":"GU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WEI","family":"WEI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,2,8]]},"reference":[{"key":"key20180107210816_b1-or-35-04-2373","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"key20180107210816_b2-or-35-04-2373","doi-asserted-by":"crossref","first-page":"a021444","DOI":"10.1101\/cshperspect.a021444","article-title":"Hepatocellular carcinoma","volume":"5","author":"Buendia","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"key20180107210816_b3-or-35-04-2373","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00117-011-2211-1","article-title":"Transarterial ablation of hepatocellular carcinoma. Status and developments","volume":"52","author":"Radeleff","year":"2012","journal-title":"Radiologe"},{"key":"key20180107210816_b4-or-35-04-2373","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1148\/radiol.11110144","article-title":"Local-regional treatment of hepatocellular carcinoma","volume":"262","author":"Lencioni","year":"2012","journal-title":"Radiology"},{"issue":"Suppl 1","key":"key20180107210816_b5-or-35-04-2373","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/S0168-8278(12)60009-9","article-title":"Management of HCC","volume":"56","author":"de Lope","year":"2012","journal-title":"J Hepatol"},{"key":"key20180107210816_b6-or-35-04-2373","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/nrm2297","article-title":"TGFbeta-SMAD signal transduction: Molecular specificity and functional flexibility","volume":"8","author":"Schmierer","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20180107210816_b7-or-35-04-2373","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3810","article-title":"Targeting the TGF\u03b2 signalling pathway in disease","volume":"11","author":"Akhurst","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"key20180107210816_b8-or-35-04-2373","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.phrs.2014.05.005","article-title":"TGF-\u03b2 signaling pathway as a pharmacological target in liver diseases","volume":"85","author":"Zhang","year":"2014","journal-title":"Pharmacol Res"},{"key":"key20180107210816_b9-or-35-04-2373","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-beta family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"key":"key20180107210816_b10-or-35-04-2373","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0092-8674(91)90073-8","article-title":"Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system","volume":"67","author":"L\u00f3pez-Casillas","year":"1991","journal-title":"Cell"},{"key":"key20180107210816_b11-or-35-04-2373","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0092-8674(91)90074-9","article-title":"Expression cloning and characterization of the TGF-beta type III receptor","volume":"67","author":"Wang","year":"1991","journal-title":"Cell"},{"key":"key20180107210816_b12-or-35-04-2373","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-beta signaling from cell membrane to the nucleus","volume":"113","author":"Shi","year":"2003","journal-title":"Cell"},{"key":"key20180107210816_b13-or-35-04-2373","first-page":"tr4","article-title":"The TGF-beta signal transduction pathway","volume":"3","author":"Thatcher","year":"2010","journal-title":"Sci Signal"},{"key":"key20180107210816_b14-or-35-04-2373","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1042\/BSR20150141","article-title":"Overexpression of transforming growth factor type III receptor restores TGF-\u03b21 sensitivity in human tongue squamous cell carcinoma cells","volume":"35","author":"Li","year":"2015","journal-title":"Biosci Rep"},{"key":"key20180107210816_b15-or-35-04-2373","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1091\/mbc.E15-04-0203","article-title":"T\u03b2RIII independently binds type I and type II TGF-\u03b2 receptors to inhibit TGF-\u03b2 signaling","volume":"26","author":"Tazat","year":"2015","journal-title":"Mol Biol Cell"},{"key":"key20180107210816_b16-or-35-04-2373","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1172\/JCI29293","article-title":"The type III TGF-beta receptor suppresses breast cancer progression","volume":"117","author":"Dong","year":"2007","journal-title":"J Clin Invest"},{"key":"key20180107210816_b17-or-35-04-2373","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1158\/0008-5472.CAN-06-3117","article-title":"The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer","volume":"67","author":"Turley","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107210816_b18-or-35-04-2373","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/carcin\/bgm289","article-title":"TbetaRIII suppresses non-small cell lung cancer invasiveness and tumorigenicity","volume":"29","author":"Finger","year":"2008","journal-title":"Carcinogenesis"},{"key":"key20180107210816_b19-or-35-04-2373","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.1158\/0008-5472.CAN-07-0035","article-title":"Loss of betaglycan expression in ovarian cancer: Role in motility and invasion","volume":"67","author":"Hempel","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107210816_b20-or-35-04-2373","doi-asserted-by":"crossref","first-page":"12862","DOI":"10.1074\/jbc.272.19.12862","article-title":"Expression of transforming growth factor beta (TGFbeta) type III receptor restores autocrine TGFbeta1 activity in human breast cancer MCF-7 cells","volume":"272","author":"Chen","year":"1997","journal-title":"J Biol Chem"},{"key":"key20180107210816_b21-or-35-04-2373","doi-asserted-by":"crossref","first-page":"25367","DOI":"10.1074\/jbc.272.40.25367","article-title":"Expression of transforming growth factor beta type III receptor suppresses tumorigenicity of human breast cancer MDA-MB-231 cells","volume":"272","author":"Sun","year":"1997","journal-title":"J Biol Chem"},{"key":"key20180107210816_b22-or-35-04-2373","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1242\/dev.111.1.131","article-title":"Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo","volume":"111","author":"Millan","year":"1991","journal-title":"Development"},{"key":"key20180107210816_b23-or-35-04-2373","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ncb434","article-title":"Differentiation plasticity regulated by TGF-beta family proteins in development and disease","volume":"9","author":"Derynck","year":"2007","journal-title":"Nat Cell Biol"},{"key":"key20180107210816_b24-or-35-04-2373","doi-asserted-by":"crossref","first-page":"8143","DOI":"10.7314\/APJCP.2014.15.19.8143","article-title":"TGF-\u03b21 protein expression in non-small cell lung cancers is correlated with prognosis","volume":"15","author":"Huang","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20180107210816_b25-or-35-04-2373","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.3892\/ol.2014.2448","article-title":"Expression and significance of transforming growth factor-\u03b21 in epithelial ovarian cancer and its extracellular matrix","volume":"8","author":"Chen","year":"2014","journal-title":"Oncol Lett"},{"key":"key20180107210816_b26-or-35-04-2373","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3748\/wjg.v12.i4.644","article-title":"Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma","volume":"12","author":"Ji","year":"2006","journal-title":"World J Gastroenterol"},{"key":"key20180107210816_b27-or-35-04-2373","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0002-9610(99)00012-4","article-title":"Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma","volume":"177","author":"Abou-Shady","year":"1999","journal-title":"Am J Surg"},{"key":"key20180107210816_b28-or-35-04-2373","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00005792-199705000-00007","article-title":"Clinical relevance of transforming growth factor-beta 1 in the urine of patients with hepatocellular carcinoma","volume":"76","author":"Tsai","year":"1997","journal-title":"Medicine"},{"key":"key20180107210816_b29-or-35-04-2373","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/carcin\/bgn049","article-title":"Expression of the type III TGF-beta receptor is negatively regulated by TGF-beta","volume":"29","author":"Hempel","year":"2008","journal-title":"Carcinogenesis"},{"key":"key20180107210816_b30-or-35-04-2373","first-page":"912","article-title":"The expression of type III TGF-\u03b2 receptor in diethylnitrosamine-induced liver cancer model","volume":"50","author":"Zhang","year":"2015","journal-title":"Acta Univ Medicinalis Anhui"},{"key":"key20180107210816_b31-or-35-04-2373","first-page":"475","article-title":"Down-regulation of transforming growth factor \u03b2 receptor type III in hepatocellular carcinoma is not directly associated with genetic alterations or loss of heterozygosity","volume":"22","author":"Bae","year":"2009","journal-title":"Oncol Rep"},{"key":"key20180107210816_b32-or-35-04-2373","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/pros.20526","article-title":"TGFBR3 loss and consequences in prostate cancer","volume":"67","author":"Sharifi","year":"2007","journal-title":"Prostate"},{"key":"key20180107210816_b33-or-35-04-2373","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/carcin\/bgp071","article-title":"The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2","volume":"30","author":"You","year":"2009","journal-title":"Carcinogenesis"},{"key":"key20180107210816_b34-or-35-04-2373","doi-asserted-by":"crossref","first-page":"32491","DOI":"10.1074\/jbc.M704434200","article-title":"Modulation of NFkappaB activity and E-cadherin by the type III transforming growth factor beta receptor regulates cell growth and motility","volume":"282","author":"Criswell","year":"2007","journal-title":"J Biol Chem"},{"key":"key20180107210816_b35-or-35-04-2373","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1158\/1078-0432.CCR-08-0546","article-title":"Type III transforming growth factor-beta (TGF-beta) receptor mediates apoptosis in renal cell carcinoma independent of the canonical TGF-beta signaling pathway","volume":"14","author":"Margulis","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20180107210816_b36-or-35-04-2373","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.biopha.2010.01.006","article-title":"Inhibition of type III TGF-\u03b2 receptor aggravates lung fibrotic process","volume":"64","author":"Ahn","year":"2010","journal-title":"Biomed Pharmacother"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2016.4615\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T16:33:53Z","timestamp":1654274033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2016.4615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,8]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,2,8]]},"published-print":{"date-parts":[[2016,4]]}},"alternative-id":["10.3892\/or.2016.4615"],"URL":"https:\/\/doi.org\/10.3892\/or.2016.4615","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,8]]}}}